Sign in

CIK 0001802665

  • Large accelerated filer

Harmony Biosciences Holdings, Inc.

Sign in to watch
Ticker
HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822279923
Phone
+1 484-539-9800
Business address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,108,586
in 2 filings

Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Budur Kumar −$3.1M CHIEF MEDICAL OFFICER sold 85% of stake
Date Insider Transaction Shares Price Value Owned after
2020-08-21 Serafin Andrew Chief Business Officer Conversion · Series C Preferred Stock −51,021 0
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion +10,139,645 10,984,981
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion +233,052 11,218,033
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion · Series A Preferred Stock −75,000,000 0
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion · Series C Preferred Stock −1,786,985 0
2020-08-21 Novo Holdings A/S 10% owner Conversion +4,277,300 4,277,300
2020-08-21 Novo Holdings A/S 10% owner Purchase +132,503 $24.00 $3.2M 4,409,803
2020-08-21 Novo Holdings A/S 10% owner Conversion · Series A Convertible Preferred Stock −25,000,000 0
2020-08-21 Novo Holdings A/S 10% owner Conversion · Series C Convertible Preferred Stock −1,860,107 0
2020-08-21 Marshman Fund Trust II 10% owner Conversion +4,026,784 10,958,547
2020-08-21 Marshman Fund Trust II 10% owner Conversion · Series A Preferred Stock −25,983,571 0
2020-08-21 Serafin Andrew Chief Business Officer Conversion +32,214 32,214
2020-08-21 Serafin Andrew Chief Business Officer Conversion +6,871 39,085
2020-08-21 Serafin Andrew Chief Business Officer Conversion · Series A Preferred Stock −207,869 0
2020-08-21 Serafin Andrew Chief Business Officer Conversion · Series C Preferred Stock −51,681 0
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion +12,080,352 12,925,688
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion +240,668 13,166,357
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion · Series A Preferred Stock −77,950,712 0
2020-08-21 Valor IV Pharma Holdings, LLC 10% owner Conversion · Series C Preferred Stock −1,810,126 0
2020-08-21 Nielsen Jack Director Purchase +24,812 $24.00 $595K 27,548

Page 25 of 26 · 511 trades